AGPHD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.533700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.584400E-02
Normal-vs-Stage2
1.123590E-01
Normal-vs-Stage3
9.325900E-02
Normal-vs-Stage4
1.514990E-01
Stage1-vs-Stage2
8.795700E-03
Stage1-vs-Stage3
2.794400E-02
Stage1-vs-Stage4
5.889600E-01
Stage2-vs-Stage3
2.617800E-01
Stage2-vs-Stage4
1.945390E-01
Stage3-vs-Stage4
3.428200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.951700E-02
Normal-vs-AfricanAmerican
9.454300E-02
Normal-vs-Asian
2.857200E-01
Caucasian-vs-AfricanAmerican
7.744400E-01
Caucasian-vs-Asian
4.946800E-01
AfricanAmerican-vs-Asian
5.401200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.028840E-01
Normal-vs-Female
9.704000E-02
Male-vs-Female
4.791600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.892400E-02
Normal-vs-Age(41-60Yrs)
1.788650E-01
Normal-vs-Age(61-80Yrs)
8.771900E-02
Normal-vs-Age(81-100Yrs)
2.331500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.741800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.365900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.998200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.533600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.884600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.928800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.848100E-02
Normal-vs-Daily Drinker
1.782820E-01
Normal-vs-Weekly Drinker
6.253800E-02
Normal-vs-Occasional Drinker
2.152000E-01
Normal-vs-Social Drinker
1.680030E-01
Non Drinker-vs-Daily Drinker
4.028400E-01
Non Drinker-vs-Weekly Drinker
8.842000E-01
Non Drinker-vs-Occasional Drinker
3.517600E-01
Non Drinker-vs-Social Drinker
4.232800E-01
Daily Drinker-vs-Weekly Drinker
5.446000E-01
Daily Drinker-vs-Occasional Drinker
8.852800E-01
Daily Drinker-vs-Social Drinker
9.668000E-01
Weekly Drinker-vs-Occasional Drinker
4.737400E-01
Weekly Drinker-vs-Social Drinker
5.268800E-01
Occasional Drinker-vs-Social Drinker
9.240000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.220800E-01
Normal-vs-Grade 2
6.747400E-01
Normal-vs-Grade 3
8.663200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.967400E-01
Grade 1-vs-Grade 3
8.424600E-01
Grade 1-vs-Grade 4
9.220800E-01
Grade 2-vs-Grade 3
3.378000E-01
Grade 2-vs-Grade 4
6.747400E-01
Grade 3-vs-Grade 4
8.663200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.308200E-02
Normal-vs-NonDiabetic
1.170600E-01
Diabetic-vs-NonDiabetic
5.978600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.739800E-02
Normal-vs-NoPancreatitis
9.984300E-02
Pancreatitis-vs-NoPancreatitis
5.955800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.044400E-02
Normal-vs-N1
1.064820E-01
N0-vs-N1
2.606000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.588200E-02
Normal-vs-TP53-NonMutant
9.512200E-02
TP53-Mutant-vs-TP53-NonMutant
7.913200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
